BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19912254)

  • 1. Recipient NOD2/CARD15 status affects cellular infiltrates in human intestinal graft-versus-host disease.
    Landfried K; Bataille F; Rogler G; Brenmoehl J; Kosovac K; Wolff D; Hilgendorf I; Hahn J; Edinger M; Hoffmann P; Obermeier F; Schoelmerich J; Andreesen R; Holler E
    Clin Exp Immunol; 2010 Jan; 159(1):87-92. PubMed ID: 19912254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of NOD2/CARD15 variants in T-cell depleted allogeneic stem cell transplantation.
    Granell M; Urbano-Ispizua A; Aróstegui JI; Fernández-Avilés F; Martínez C; Rovira M; Rius J; Plaza S; Gaya A; Navarro A; Talarn C; Carreras E; Monzó M; Montserrat E; Yagüe J
    Haematologica; 2006 Oct; 91(10):1372-6. PubMed ID: 17018387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NOD2/CARD15 single nucleotide polymorphism 13 (3020insC) is associated with risk of sepsis and single nucleotide polymorphism 8 (2104C>T) with herpes viruses reactivation in patients after allogeneic hematopoietic stem cell transplantation.
    Jaskula E; Lange A; Kyrcz-Krzemien S; Markiewicz M; Dzierzak-Mietla M; Jedrzejczak WW; Czajka P; Mordak-Domagala M; Lange J; Gronkowska A; Nowak J; Warzocha K; Hellmann A; Kowalczyk J; Drabko K; Gozdzik J; Mizia S;
    Biol Blood Marrow Transplant; 2014 Mar; 20(3):409-14. PubMed ID: 24345423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recipient NOD2/CARD15 variants: a novel independent risk factor for the development of bronchiolitis obliterans after allogeneic stem cell transplantation.
    Hildebrandt GC; Granell M; Urbano-Ispizua A; Wolff D; Hertenstein B; Greinix HT; Brenmoehl J; Schulz C; Dickinson AM; Hahn J; Rogler G; Andreesen R; Holler E
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):67-74. PubMed ID: 18158963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation.
    Holler E; Rogler G; Herfarth H; Brenmoehl J; Wild PJ; Hahn J; Eissner G; Schölmerich J; Andreesen R
    Blood; 2004 Aug; 104(3):889-94. PubMed ID: 15090455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single nucleotide polymorphisms in the NOD2/CARD15 gene are associated with an increased risk of relapse and death for patients with acute leukemia after hematopoietic stem-cell transplantation with unrelated donors.
    Mayor NP; Shaw BE; Hughes DA; Maldonado-Torres H; Madrigal JA; Keshav S; Marsh SG
    J Clin Oncol; 2007 Sep; 25(27):4262-9. PubMed ID: 17724347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of genetic variants of NOD2/CARD15, a receptor of the innate immune system, in GvHD and complications following related and unrelated donor haematopoietic stem cell transplantation.
    Holler E; Rogler G; Brenmoehl J; Hahn J; Greinix H; Dickinson AM; Socie G; Wolff D; Finke J; Fischer G; Jackson G; Rocha V; Hilgendorf I; Eissner G; Marienhagen J; Andreesen R
    Int J Immunogenet; 2008 Aug; 35(4-5):381-4. PubMed ID: 18976442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism of interleukin-23 receptor gene but not of NOD2/CARD15 is associated with graft-versus-host disease after hematopoietic stem cell transplantation in children.
    Gruhn B; Intek J; Pfaffendorf N; Zell R; Corbacioglu S; Zintl F; Beck JF; Debatin KM; Steinbach D
    Biol Blood Marrow Transplant; 2009 Dec; 15(12):1571-7. PubMed ID: 19896081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NOD2/CARD15 variants are not a risk factor for clinical outcome after nonmyeloablative allogeneic stem cell transplantation.
    van der Straaten HM; Paquay MM; Tilanus MG; van Geloven N; Verdonck LF; Huisman C
    Biol Blood Marrow Transplant; 2011 Aug; 17(8):1231-6. PubMed ID: 21215810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insufficient evidence for association of NOD2/CARD15 or other inflammatory bowel disease-associated markers on GVHD incidence or other adverse outcomes in T-replete, unrelated donor transplantation.
    Nguyen Y; Al-Lehibi A; Gorbe E; Li E; Haagenson M; Wang T; Spellman S; Lee SJ; Davidson NO
    Blood; 2010 Apr; 115(17):3625-31. PubMed ID: 20177049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NOD2 regulates CXCR3-dependent CD8+ T cell accumulation in intestinal tissues with acute injury.
    Wu X; Lahiri A; Haines GK; Flavell RA; Abraham C
    J Immunol; 2014 Apr; 192(7):3409-18. PubMed ID: 24591373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of NOD2/CARD15 haplotypes on the outcome after kidney transplantation.
    Krüger B; Böger CA; Schröppel B; Obed A; Hoffmann U; Murphy BT; Fischereder M; Holler E; Banas B; Krämer BK
    Transpl Int; 2007 Jul; 20(7):600-7. PubMed ID: 17498224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel technique for NOD2/CARD15 genotyping using PCR-SSP.
    Mayor NP; Shaw BE; Keshav S; Madrigal JA; Marsh SG
    J Immunol Methods; 2007 Oct; 327(1-2):82-7. PubMed ID: 17719603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteopontin attenuates acute gastrointestinal graft-versus-host disease by preventing apoptosis of intestinal epithelial cells.
    Kawakami K; Minami N; Matsuura M; Iida T; Toyonaga T; Nagaishi K; Arimura Y; Fujimiya M; Uede T; Nakase H
    Biochem Biophys Res Commun; 2017 Apr; 485(2):468-475. PubMed ID: 28192120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD.
    Rieger K; Loddenkemper C; Maul J; Fietz T; Wolff D; Terpe H; Steiner B; Berg E; Miehlke S; Bornhäuser M; Schneider T; Zeitz M; Stein H; Thiel E; Duchmann R; Uharek L
    Blood; 2006 Feb; 107(4):1717-23. PubMed ID: 16278306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NOD2/CARD15 gene variants are linked to failure of antibiotic treatment in perianal fistulating Crohn's disease.
    Angelberger S; Reinisch W; Dejaco C; Miehsler W; Waldhoer T; Wehkamp J; Lichtenberger C; Schaeffeler E; Vogelsang H; Schwab M; Teml A
    Am J Gastroenterol; 2008 May; 103(5):1197-202. PubMed ID: 18371140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No impact of NOD2/CARD15 on outcome after SCT.
    Sairafi D; Uzunel M; Remberger M; Ringdén O; Mattsson J
    Bone Marrow Transplant; 2008 Jun; 41(11):961-4. PubMed ID: 18317454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variants in the NOD2/CARD15 gene are associated with early mortality in sepsis patients.
    Brenmoehl J; Herfarth H; Glück T; Audebert F; Barlage S; Schmitz G; Froehlich D; Schreiber S; Hampe J; Schölmerich J; Holler E; Rogler G
    Intensive Care Med; 2007 Sep; 33(9):1541-8. PubMed ID: 17558494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variations of interleukin-23R (1143A>G) and BPI (A645G), but not of NOD2, are associated with acute graft-versus-host disease after allogeneic transplantation.
    Wermke M; Maiwald S; Schmelz R; Thiede C; Schetelig J; Ehninger G; Bornhäuser M; Wassmuth R
    Biol Blood Marrow Transplant; 2010 Dec; 16(12):1718-27. PubMed ID: 20541026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic transplantation.
    Elmaagacli AH; Koldehoff M; Hindahl H; Steckel NK; Trenschel R; Peceny R; Ottinger H; Rath PM; Ross RS; Roggendorf M; Grosse-Wilde H; Beelen DW
    Transplantation; 2006 Jan; 81(2):247-54. PubMed ID: 16436969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.